Due to our findings of RECK/EMMPRIN imbalance in urothelial bladder carcinoma [6], which could promote invasion processes, we decided to look not only at RECK, but also at the EMMPRIN counterpart in renal cell carcinoma. The gene discussed is RECK; the disease is hereditary clear cell renal cell carcinoma.